Crude and adjusted HRs in patients with an indication for CRT between those with CRT and without CRT for all-cause of death, CVD, and first HFH at 5 and 10 years from the indication
CRT vs. not CRT . | All-cause of death . | CVD . | First HFH . | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | CI . | P-value . | 10 years . | 95% CI . | P-value . | |
Crude HR | 0.30 | 0.24–0.36 | <0.001 | 0.40 | 0.28–0.58 | <0.001 | 0.30 | 0.23–0.39 | <0.001 | 0.38 | 0.25–0.59 | <0.001 | 0.43 | 0.37–0.50 | <0.001 | 1.12 | 0.59–2.12 | 0.741 |
Adjusted HR | 0.45 | 0.36–0.57 | <0.001 | 0.67 | 0.45–0.99 | 0.047 | 0.47 | 0.35–0.63 | <0.001 | 0.67 | 0.41–1.10 | 0.110 | 0.56 | 0.48–0.66 | <0.001 | 1.34 | 0.68–2.65 | 0.402 |
CRT vs. not CRT . | All-cause of death . | CVD . | First HFH . | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | CI . | P-value . | 10 years . | 95% CI . | P-value . | |
Crude HR | 0.30 | 0.24–0.36 | <0.001 | 0.40 | 0.28–0.58 | <0.001 | 0.30 | 0.23–0.39 | <0.001 | 0.38 | 0.25–0.59 | <0.001 | 0.43 | 0.37–0.50 | <0.001 | 1.12 | 0.59–2.12 | 0.741 |
Adjusted HR | 0.45 | 0.36–0.57 | <0.001 | 0.67 | 0.45–0.99 | 0.047 | 0.47 | 0.35–0.63 | <0.001 | 0.67 | 0.41–1.10 | 0.110 | 0.56 | 0.48–0.66 | <0.001 | 1.34 | 0.68–2.65 | 0.402 |
CI, confidence interval; CRT, cardiac resynchronization therapy; CVD, cardiovascular death; HFH, heart failure hospitalization; HR, hazard ratio; vs., versus.
Crude and adjusted HRs in patients with an indication for CRT between those with CRT and without CRT for all-cause of death, CVD, and first HFH at 5 and 10 years from the indication
CRT vs. not CRT . | All-cause of death . | CVD . | First HFH . | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | CI . | P-value . | 10 years . | 95% CI . | P-value . | |
Crude HR | 0.30 | 0.24–0.36 | <0.001 | 0.40 | 0.28–0.58 | <0.001 | 0.30 | 0.23–0.39 | <0.001 | 0.38 | 0.25–0.59 | <0.001 | 0.43 | 0.37–0.50 | <0.001 | 1.12 | 0.59–2.12 | 0.741 |
Adjusted HR | 0.45 | 0.36–0.57 | <0.001 | 0.67 | 0.45–0.99 | 0.047 | 0.47 | 0.35–0.63 | <0.001 | 0.67 | 0.41–1.10 | 0.110 | 0.56 | 0.48–0.66 | <0.001 | 1.34 | 0.68–2.65 | 0.402 |
CRT vs. not CRT . | All-cause of death . | CVD . | First HFH . | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | 95% CI . | P-value . | 10 years . | 95% CI . | P-value . | 5 years . | CI . | P-value . | 10 years . | 95% CI . | P-value . | |
Crude HR | 0.30 | 0.24–0.36 | <0.001 | 0.40 | 0.28–0.58 | <0.001 | 0.30 | 0.23–0.39 | <0.001 | 0.38 | 0.25–0.59 | <0.001 | 0.43 | 0.37–0.50 | <0.001 | 1.12 | 0.59–2.12 | 0.741 |
Adjusted HR | 0.45 | 0.36–0.57 | <0.001 | 0.67 | 0.45–0.99 | 0.047 | 0.47 | 0.35–0.63 | <0.001 | 0.67 | 0.41–1.10 | 0.110 | 0.56 | 0.48–0.66 | <0.001 | 1.34 | 0.68–2.65 | 0.402 |
CI, confidence interval; CRT, cardiac resynchronization therapy; CVD, cardiovascular death; HFH, heart failure hospitalization; HR, hazard ratio; vs., versus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.